Stampidine

Drugbox
IUPAC_name = Methyl (2"R")-2- [ [(4-bromophenoxy)- [ [(2"S",5"R")-5-(5-methyl-2, 4-dioxopyrimidin-1-yl)- 2,5-dihydrofuran-2-yl] methoxy] phosphoryl] amino] propanoate

---

CAS_number =
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 469782
DrugBank =
C=20 | H=23 | Br=1 | N=3 | O=8 | P=1
molecular_weight = 544.289 g/mol
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration =

Stampidine is an experimental nucleoside reverse transcriptase inhibitor (NRTI).

It is a derivative of d4T (stavudine, Zerit), and has been designed to avoid dependence on the rate limiting step of phosphorylation of stavudine to stavudine monophosphate. This is governed by the supply of thymidine kinase that is available, and stavudine is poorly phosphorylated to its monophosphate form in thymidine kinase-deficient cells. [ [http://www.aidsmap.com/cms1032424.asp aidsmap.com | Stampidine ] ]

References